Peter T. Slover

VP, Finance and Operations, ANADYS PHARMACEUTICALS INC.

Companies

Contineum Therapeutics, Inc.Chief financial officer Apr 4, 2024 to now¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARContineum Therapeutics, Inc., Chief financial officer